Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway-Reference-Cited by-同舟云学术

Lenalidomide attenuates post-inflammation pulmonary fibrosis through blocking NF-κB signaling pathway

Published:2022-02 Issue: Volume:103 Page:108470
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Li Xiaohe,Liang Qing,Gao Shaoyan,Jiang Qiuyan,Zhang Fangxia,Zhang Ruiqin,Ruan Hao,Li Shuangling,Luan Jiaoyan,Deng Ruxia,Zhou Honggang,Huang Hui,Yang Cheng

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference34 articles.

1. Idiopathic pulmonary fibrosis;King;Lancet,2011

2. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline;Raghu;Am. J. Respir. Crit. Care Med.,2015

3. Therapeutic targets and early stage clinical trials for pulmonary fibrosis;Sato;Expert Opin. Invest. Drugs,2019

4. Novel management strategies for idiopathic pulmonary fibrosis;Ahmad;Exp. Rev. Respir. Med.,2018

5. Management of fibrosing interstitial lung diseases;Maher;Adv. Ther.,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring TβRI inhibitors from Arenaria kansuensis based on 3D-QSAR, molecular docking and molecular dynamics simulation methods and its anti-pulmonary fibrosis molecular mechanism validation;Journal of Ethnopharmacology;2025-01

2. Aging of alveolar type 2 cells induced by <i>Lonp1</i> deficiency exacerbates pulmonary fibrosis;Biomolecules and Biomedicine;2024-09-06

3. Single-cell transcriptomics reveals CD8+ T cell structure and developmental trajectories in idiopathic pulmonary fibrosis;Molecular Immunology;2024-08

4. Persistent remission of severe rheumatoid arthritis associated with myelodysplastic syndrome upon treatment with lenalidomide;Joint Bone Spine;2024-05

5. Chinese medicine as a therapeutic option for pulmonary fibrosis: Clinical efficacies and underlying mechanisms;Journal of Ethnopharmacology;2024-01